News

GLP-1 receptor agonists (GLP-1-RAs) have become the wonder drug not only of weight loss, but also for improving cardiovascular health in a growing number of positive cardiovascular trials. The latest study of more than 13,000 patients presented at Heart Rhythm 2026 this week showed the GLP-1 reduce atrial fibrillation (AFib) and survival, even after accounting for the drug’s impact on weight loss.

Multiple GLP-1 drugs linked to lower AFib risk

The popular drugs, originally developed to treat diabetes, were also associated with an improved survival rate. Benefits were seen in patients who did and did not lose significant weight as a result of treatment.

Lawmakers introduce bipartisan bill to speed up prior authorization in Medicare Advantage

Several healthcare stakeholders have voiced their support for the effort, including the Medical Group Management Association.

Radiologists among docs most optimistic about profession’s short-term future

However, radiology dropped to 18th on the list of specialists when asked how they feel about their profession’s long-term future, according to new survey data from Medscape.

survey polling quick data check mark poll research doctor

Current political climate having 'detrimental' effect on radiology research, survey says

Published in Clinical Imaging, the responses indicate that Trump administration policies have made it more difficult to acquire funding and collaborate with other researchers.

Hospital's poor radiation safety protocols led to cancer 'cluster' among staff, rad tech claims

The technologist, who was diagnosed with aggressive lymphoma in 2023, says she previously took her concerns to leadership, but her claims were not taken seriously.

FTC shuts down alleged health insurance fraud scheme involving the sale of low-quality plans

The owners of several telemarketing companies, along with the organizations themselves, have been named as defendants in a federal lawsuit. The Federal Trade Commission alleges that the group would sell bundled services as supposed “PPO” plans, leaving patients to discover that services were not covered.

Prime places to work as a nurse in 2026

Like a mirror image on a USA map folded in half vertically, the four best states for nurses are two nextdoor neighbors in the upper Northeast and two in the Pacific Northwest.

Example of a RF burn from an MRI scan where a sedated patient's identification bracelet was touching their skin during an exam. Image courtesy of RSNA. https://pubs.rsna.org/doi/10.1148/radiol.09090637

FDA: CVS and MediHoney wound gels recalled after 14 serious injuries

The wound and burn gels are manufactured by Integra LifeSciences. Defective packaging could cause the sterile barrier to fail, exposing the gels to pathogens. Due to the risk of severe infections, all recalled products must be removed from where they are used and sold.

Signs of Alzheimer's evident on imaging up to 15 years prior to symptom onset in Down syndrome population

By identifying these structural changes prior to the onset of symptomatic neurodegeneration, providers may be able to initiate preventive therapies sooner.

artificial intelligence AI explainable ethical responsible

‘Life or death consequences’: AMA pushes for greater transparency in imaging AI

The American Medical Association passed a resolution at its recent annual meeting seeking to “maximize trust” around how these models reach conclusions.

Bristol Myers Squibb will pay $350M-plus to add prostate cancer imaging agent

Subsidiary RayzeBio has inked a definitive deal to license the worldwide rights for the drug from Philochem, a Swiss biotechnology firm.

healthcare insurance fraud scam scheme legal lawsuit

Fraud prevention expert charged with over 167 suspected incidents of healthcare fraud

Faranak Firozan, 47, is a cybersecurity expert at Nvidia who regularly spoke on the topic of “cyber laundering.” Prosecutors in California allege she submitted fraudulent medical claims to an employer-sponsored insurance plan, bilking Cigna out of $100,000.

Around the web

Cardiovascular Business

Multiple GLP-1 drugs linked to lower AFib risk